Jeffrey M. Jonas

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Meredith Prithviraj by Power of Attorney for Jeffrey M. Jonas
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jeffrey M. Jonas

Form 4 holding Director

Sage Therapeutics, Inc.

Security class
Common Stock
Shares / value
128,046
Estimated value
$2,467,446
Report date
28 Nov 2023
Price
$19.27
Ownership
Direct
Form 4 holding Director

Generation Bio Co.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
$275,400
Report date
09 Feb 2026
Price
$4.59
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Karuna Therapeutics, Inc.

Security class
Option (right to buy)
Shares / value
0
Estimated value
$0
Report date
18 Mar 2024
Price
$92.30
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Sage Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
12,500
Estimated value
Report date
10 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Jeffrey M. Jonas

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .